Medtronic Shares Outstanding 2012-2025 | MDT
Medtronic shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Medtronic shares outstanding for the quarter ending October 31, 2025 were 1.288B, a 0.09% increase year-over-year.
- Medtronic 2025 shares outstanding were 1.29B, a 3.03% decline from 2024.
- Medtronic 2024 shares outstanding were 1.33B, a 0.2% decline from 2023.
- Medtronic 2023 shares outstanding were 1.333B, a 1.38% decline from 2022.
|
Medtronic Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 1,290 |
| 2024 | 1,330 |
| 2023 | 1,333 |
| 2022 | 1,351 |
| 2021 | 1,354 |
| 2020 | 1,351 |
| 2019 | 1,358 |
| 2018 | 1,368 |
| 2017 | 1,391 |
| 2016 | 1,426 |
| 2015 | 1,109 |
| 2014 | 1,014 |
| 2013 | 1,028 |
| 2012 | 1,060 |
| 2011 | 1,082 |
|
Medtronic Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-10-31 | 1,288 |
| 2025-07-31 | 1,287 |
| 2025-04-30 | 1,290 |
| 2025-01-31 | 1,286 |
| 2024-10-31 | 1,287 |
| 2024-07-31 | 1,297 |
| 2024-04-30 | 1,330 |
| 2024-01-31 | 1,332 |
| 2023-10-31 | 1,332 |
| 2023-07-31 | 1,334 |
| 2023-04-30 | 1,333 |
| 2023-01-31 | 1,332 |
| 2022-10-31 | 1,332 |
| 2022-07-31 | 1,335 |
| 2022-04-30 | 1,351 |
| 2022-01-31 | 1,350 |
| 2021-10-31 | 1,355 |
| 2021-07-31 | 1,356 |
| 2021-04-30 | 1,354 |
| 2021-01-31 | 1,356 |
| 2020-10-31 | 1,352 |
| 2020-07-31 | 1,350 |
| 2020-04-30 | 1,351 |
| 2020-01-31 | 1,352 |
| 2019-10-31 | 1,351 |
| 2019-07-31 | 1,352 |
| 2019-04-30 | 1,358 |
| 2019-01-31 | 1,353 |
| 2018-10-31 | 1,361 |
| 2018-07-31 | 1,365 |
| 2018-04-30 | 1,368 |
| 2018-01-31 | 1,354 |
| 2017-10-31 | 1,366 |
| 2017-07-31 | 1,376 |
| 2017-04-30 | 1,391 |
| 2017-01-31 | 1,383 |
| 2016-10-31 | 1,393 |
| 2016-07-31 | 1,407 |
| 2016-04-30 | 1,426 |
| 2016-01-31 | 1,422 |
| 2015-10-31 | 1,429 |
| 2015-07-31 | 1,436 |
| 2015-04-30 | 1,109 |
| 2015-01-31 | 996 |
| 2014-10-31 | 993 |
| 2014-07-31 | 1,005 |
| 2014-04-30 | 1,014 |
| 2014-01-31 | 1,010 |
| 2013-10-31 | 1,009 |
| 2013-07-31 | 1,021 |
| 2013-04-30 | 1,028 |
| 2013-01-31 | 1,021 |
| 2012-10-31 | 1,028 |
| 2012-07-31 | 1,037 |
| 2012-04-30 | 1,060 |
| 2012-01-31 | 1,060 |
| 2011-10-31 | 1,063 |
| 2011-07-31 | 1,070 |
| 2011-04-30 | 1,082 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $131.983B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.676B | 21.18 |
| EssilorLuxottica (ESLOY) | France | $140.849B | 0.00 |
| Stryker (SYK) | United States | $138.598B | 26.59 |
| Boston Scientific (BSX) | United States | $115.097B | 25.46 |
| Medline (MDLN) | United States | $60.694B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.604B | 0.00 |
| ResMed (RMD) | United States | $38.903B | 25.98 |
| GE HealthCare Technologies (GEHC) | United States | $37.513B | 17.97 |
| Agilent Technologies (A) | United States | $36.753B | 23.23 |
| Koninklijke Philips (PHG) | Netherlands | $27.809B | 18.16 |
| Terumo (TRUMY) | Japan | $18.896B | 21.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Insulet (PODD) | United States | $17.105B | 53.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.943B | 0.00 |
| Baxter (BAX) | United States | $11.191B | 9.03 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.080B | 29.05 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.301B | 13.10 |
| Envista Holdings (NVST) | United States | $4.063B | 20.59 |
| BillionToOne (BLLN) | United States | $3.897B | 0.00 |
| ICU Medical (ICUI) | United States | $3.694B | 23.45 |
| Prestige Consumer Healthcare (PBH) | United States | $3.152B | 14.63 |
| Haemonetics (HAE) | United States | $3.044B | 13.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.014B | 0.00 |
| Neogen (NEOG) | United States | $2.304B | 50.43 |
| Phibro Animal Health (PAHC) | United States | $2.027B | 17.86 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| Perrigo (PRGO) | Ireland | $1.964B | 4.92 |
| QuidelOrtho (QDEL) | United States | $1.949B | 12.53 |
| AtriCure (ATRC) | United States | $1.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.466B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.466B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| Green Thumb Industries (GTBIF) | United States | $1.417B | 62.09 |
| BioLife Solutions (BLFS) | United States | $1.060B | 314.57 |
| Capricor Therapeutics (CAPR) | United States | $1.053B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 10.59 |
| Tilray Brands (TLRY) | Canada | $0.821B | 0.00 |
| Valneva SE (VALN) | France | $0.803B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.790B | 0.00 |
| Omeros (OMER) | United States | $0.761B | 0.00 |
| CeriBell (CBLL) | United States | $0.717B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.66 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.411B | 0.00 |
| Brainsway (BWAY) | Israel | $0.410B | 69.77 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.326B | 26.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.286B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.201B | 18.06 |
| Organigram Global (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.196B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.188B | 55.17 |
| Sanara MedTech (SMTI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.175B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.69 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.49 |
| Sharps Technology (STSS) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.85 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |